Shanghai, China, October 21, 2014 – Broda Technologies Co., Ltd. today announced it has been granted Patent No. 8,865,143 from United State Patent and Trademark Office for a patent titled “Reversely Thermal-Reversible Hydrogel Compositions”.
The patent covers the Company’s key IntelliGel supramolecular drug delivery technology platform, compositions for pharmaceutical, cosmetic and personal care applications, and methods of making such compositions.
“The successful commercialization of Broda Acne System OTC products and a US investigator-lead clinical study of an anti-fungal drug demonstrated that the Company’s IntelliGel® supramolecular drug delivery technology platform has wide potential applications with enhanced efficacy, patient compliance, and safety compared with existing pharmaceutical products.” stated Broda President Dr. Shao Lu.
About Broda Technologies
Broda Technologies Co., Ltd. is a start-up company focus on supramolecular drug delivery system. The Company’s proprietary IntelliGel supramolecular drug delivery system is capable of dissolving water insoluble or sparely soluble drugs in a clear and transparent smart hydrogel with enhanced efficacy, safety and patient’s compliance. For more information, please visit www.brodatech.com.
Contact
Broda Technologies Co., Ltd.
Shao Lu, Ph.D.
Tel: +86 21 2022 5388
E-mail: sxlu@brodatech.com
Find out how our breakthrough smart supramolecular drug delivery plateform technology can help you maximizing potential of your development drug and related consumer care products.
Email: